
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT
- About


Waldencast Acquisition Corp (WALD)


- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)

(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: WALD (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $3.5
1 Year Target Price $3.5
4 | Strong Buy |
0 | Buy |
2 | Hold |
0 | Sell |
0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -48.61% | Avg. Invested days 34 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() | ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 241.10M USD | Price to earnings Ratio - | 1Y Target Price 3.5 |
Price to earnings Ratio - | 1Y Target Price 3.5 | ||
Volume (30-day avg) 6 | Beta -0.44 | 52 Weeks Range 1.48 - 4.18 | Updated Date 10/17/2025 |
52 Weeks Range 1.48 - 4.18 | Updated Date 10/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.39 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2025-09-25 | When After Market | Estimate -0.07 | Actual -0.09 |
Profitability
Profit Margin -15.5% | Operating Margin (TTM) -18.31% |
Management Effectiveness
Return on Assets (TTM) -3.32% | Return on Equity (TTM) -6.49% |
Valuation
Trailing PE - | Forward PE 45.05 | Enterprise Value 397335016 | Price to Sales(TTM) 0.88 |
Enterprise Value 397335016 | Price to Sales(TTM) 0.88 | ||
Enterprise Value to Revenue 1.45 | Enterprise Value to EBITDA 13.88 | Shares Outstanding 112644711 | Shares Floating 32850983 |
Shares Outstanding 112644711 | Shares Floating 32850983 | ||
Percent Insiders 57.01 | Percent Institutions 30.24 |
Upturn AI SWOT
Waldencast Acquisition Corp

Company Overview
History and Background
Waldencast Acquisition Corp was a special purpose acquisition company (SPAC) founded with the intent to acquire a business in the beauty and wellness sectors. It was formed in 2020 and successfully completed a merger in 2022 to form Waldencast plc.
Core Business Areas
- Personal Care: Waldencast plc (formerly Waldencast Acquisition Corp) focuses on building a global best-in-class beauty and wellness operating company. Their portfolio includes brands focused on skincare, haircare, and other personal care products.
Leadership and Structure
Michel Brousset and Hind Sebti are the co-founders and co-CEOs of Waldencast plc. The company has a board of directors composed of experienced professionals from various industries.
Top Products and Market Share
Key Offerings
- Obagi Skin Health: Obagi is a physician-dispensed skincare brand offering a range of products targeting various skin concerns. Market share is competitive within the professional skincare segment. Competitors include SkinCeuticals (L'Oreal), Revision Skincare, and ZO Skin Health.
- Milk Makeup: Milk Makeup is a Gen Z-focused makeup brand known for its vegan and cruelty-free products. It has a growing presence in the color cosmetics market. Competitors include Rare Beauty, Fenty Beauty, and e.l.f. Cosmetics.
- Nuxe: Nuxe is a French skincare brand known for its natural-origin formulas and iconic products like Huile Prodigieuse. Competitors include L'Occitane, Caudalie and other premium skincare brands.
Market Dynamics
Industry Overview
The beauty and wellness industry is experiencing growth driven by increased consumer spending, particularly in skincare and online channels. Trends include personalized beauty, sustainability, and inclusivity.
Positioning
Waldencast positions itself as a brand accelerator, acquiring and growing high-potential beauty and wellness brands. Its competitive advantage lies in its operational expertise and focus on long-term value creation.
Total Addressable Market (TAM)
The global beauty and personal care market is estimated to be hundreds of billions of dollars. Waldencast is positioned to capture a portion of this TAM by acquiring and scaling innovative brands.
Upturn SWOT Analysis
Strengths
- Experienced leadership team
- Focus on high-growth beauty and wellness brands
- Operational expertise in brand building
- Strong relationships with retailers and distributors
Weaknesses
- Reliance on acquisitions for growth
- Integration risks associated with acquired brands
- Competition from larger beauty conglomerates
- Relatively short operating history as Waldencast plc
Opportunities
- Expansion into new geographic markets
- Acquisition of additional beauty and wellness brands
- Development of innovative products and services
- Growing demand for sustainable and personalized beauty
Threats
- Changing consumer preferences
- Increased competition from established players
- Economic downturn impacting consumer spending
- Regulatory changes affecting the beauty industry
Competitors and Market Share
Key Competitors
- EL (Estee Lauder Companies Inc.)
- LRLCY (L'Oreal S.A.)
- PG (Procter & Gamble Co.)
- UL (Unilever PLC)
Competitive Landscape
Waldencast faces intense competition from established beauty conglomerates with greater resources. Its advantage lies in its focus on niche brands and operational expertise, allowing it to potentially outmaneuver larger competitors in specific segments.
Major Acquisitions
Obagi Skin Health and Milk Makeup
- Year: 2022
- Acquisition Price (USD millions): 938
- Strategic Rationale: Acquisition of Obagi and Milk Makeup aimed to create a multi-brand platform in the premium skincare and makeup categories. Obagi provides a strong foundation in professional skincare, while Milk Makeup targets a younger demographic.
Nuxe Group
- Year: 2022
- Acquisition Price (USD millions): 400
- Strategic Rationale: Acquisition of Nuxe Group adds a leading French skincare brand known for its natural-origin formulas to Waldencast's portfolio.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is tied to the performance of the acquired brands and the company's ability to integrate and scale them.
Future Projections: Future growth projections depend on successful execution of the acquisition strategy and overall market conditions. Analyst estimates for WALD will provide insights.
Recent Initiatives: Recent strategic initiatives include brand acquisitions, product launches, and expansion into new markets. Evaluating recent Waldencast press releases is helpful.
Summary
Waldencast plc is a relatively new player aiming to disrupt the beauty and wellness industry through strategic acquisitions. Its leadership has relevant experience, and the company is focused on scaling brands. However, Waldencast must effectively integrate acquisitions and compete with larger, more established players to achieve its long-term goals, and must watch out for the global economy, consumer trends, and supply chain.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company press releases
- Analyst reports (where available)
- Industry publications
Disclaimers:
This analysis is based on publicly available information and should not be considered financial advice. Market conditions and company performance are subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Waldencast Acquisition Corp
Exchange NASDAQ | Headquaters White Plains, NY, United States | ||
IPO Launch date 2021-05-12 | Founder, CEO & Director Mr. Michel Brousset | ||
Sector Consumer Defensive | Industry Household & Personal Products | Full time employees 335 | Website https://www.waldencast.com |
Full time employees 335 | Website https://www.waldencast.com |
Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The company operates through two segments, Obagi Medical and Milk Makeup. It offers skin care products to minimize signs of skin aging, address dark spots, hyperpigmentation, fine lines and wrinkles, and protect and enhance skin tone and texture; cosmetics; and other beauty products. In addition, the company provides foundation, concealer, primer, blush, setting spray, and bronzer categories, as well as sells liner, eyeshadow, and lip color products. It serves distributors, retailers, physicians, and directly to consumers through its e-commerce platforms, and third-party logistics and delivery providers. The company was incorporated in 2020 and is headquartered in White Plains, New York.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.